Itay: Researchers have found in a new study that a single postoperative dose of Mitomycin C significantly reduces early ...

Once closely tied to smoking, head and neck cancers are increasingly affecting nonsmokers, according to a news release. Mercy Health ear, nose and throat (ENT) physicians are urging patients to act on ...

Amplia and ANZGOG enter into agreement to conduct a clinical study in ovarian cancer evaluating narmafotinib in combination with standard-of-care chemotherapy Ovarian cancer represents a major target ...

A first-in-human trial of a robotic colonoscopy shows the system can perform all functions of a colonoscope with promising ...

Russell has a PhD in the history of medicine, violence, and colonialism. His research has explored topics including ethics, science governance, and medical involvement in violent contexts. Russell has ...

Natalie Hushin, a mum from Runcorn, Cheshire, wants to warn others about the symptoms of colon cancer after undergoing six ...

Samsung Bioepis Co Ltd, a biopharmaceutical company committed to realizing healthcare that is accessible to everyone, has announced that the phase 1 study on SB27, a proposed biosimilar to Keytruda ...

Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with muscle-invasive bladder cancer (MIBC).

A WOMAN who put her bloating down to menopause was diagnosed with colon cancer after noticing ‘speckled blood’ in her stool.

Pembrolizumab is a humanized monoclonal antibody that acts as an immune checkpoint inhibitor by targeting and blocking the programmed cell death protein 1 (PD-1) receptor on T cells. It is used to ...

An archived webcast will be available following the event.